This is a $21,821.80 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4 mg ondansetron hydrochloride tablets, a medication commonly used to treat nausea and vomiting. The contract has a period of performance through July 2024. Amerisourcebergen is providing these pharmaceutical products to support military treatment facilities and other federal healthcare programs. This...
This is a $27,214.48 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 500 tablet bottles of 8mg Ondansetron HCL, a medication commonly used to treat nausea and vomiting. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a...
This is a $9,986.91 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,820,742 units of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of January 3, 2025 and was awarded on January 2, 2025. AmerisourceBergen holds a larger $999,999,999...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $10,072.72 and an ultimate completion date of February 5, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4,565,439,096 units of Ondansetron HCl 4 mg Tablets, a medication used to prevent nausea and vomiting, with a ceiling value of $13,431.18. The contract has an ultimate completion date of August 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,478,068 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $7,065.42 and a completion date of January 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,501.48 firm fixed-price delivery order is for the supply of 500 units of 4 mg Ondansetron HCl tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of November 25, 2024. This award is a child contract under a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,062.35 firm fixed price contract is for the supply of 4 mg Ondansetron HCl tablets, a medication used to treat nausea and vomiting. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,119.74, is a firm fixed-price delivery order with an ultimate completion date of January 30, 2025. The contract is for the supply of 4 mg Ondansetron hydrochloride tablets, a medication used to prevent nausea and vomiting. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg Ondansetron HCL tablets, a medication used to prevent nausea and vomiting. The total ceiling value of the contract is $3,782.32, and it is a firm fixed-price contract with an ultimate completion date of April 19, 2023. The contract was not designated as a set-aside and was awarded through open competition....